As of November 2024 GlaxoSmithKline has a market cap of NZ$124.22 Billion. This makes GlaxoSmithKline the world's 264th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 12th, 2024 the market cap of GlaxoSmithKline was reported to be: